MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-01-0042790
Anexas Pharmaceuticals Private Limited - pharma in Agra, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.34 Cr
▼ 8% YoY
Net profit · FY 2025
₹1.91 Lakh
Net margin 0.4%
EBITDA · FY 2025
₹12.35 Lakh
EBITDA margin 2.8%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹70 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
6
As per MCA filings
About Anexas Pharmaceuticals Private Limited
Data last updated:
Anexas Pharmaceuticals Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2019PTC123830. Its GSTIN is 09AASCA9864D1Z2 (Uttar Pradesh).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹70 Lakh. It is led by directors including Monika Saxena and Ajeet Kumar Saxena.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 9 Jai Ram Bagh Nagla Baghel Dayal Bagh, Agra, Uttar Pradesh, India – 282005.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.34 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.91 Lakh (net margin 0.4%) and EBITDA of ₹12.35 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
As per MCA filings, the company has open charges of ₹1 Cr on record.
Anexas Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-01-0042790). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anexaspharma.com.
Company details
CIN U74999UP2019PTC123830
Registration Number 123830
Incorporation Date 26 November 2019
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-01-0042790
Recognitions & Rankings of Anexas Pharmaceuticals
Contact details
Anexas Pharmaceuticals Private Limited's registered office is in Agra, Uttar Pradesh. Its website is anexaspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD – 9 Jai Ram Bagh Nagla Baghel Dayal Bagh, Agra, Uttar Pradesh, India – 282005
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Anexas Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Anexas Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Anexas Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Anexas Pharmaceuticals Private Limited, buy the company report.
Financials of Anexas Pharmaceuticals Private Limited
FY 2025 filings availableAnexas Pharmaceuticals Private Limited reported revenue of ₹4.34 Cr (down 8% YoY) for FY 2025.
Revenue · FY 2025
₹4.34 Cr ▼ 8%
Net profit · FY 2025
₹1.91 Lakh margin 0.4%
EBITDA · FY 2025
₹12.35 Lakh margin 2.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 7%
Revenue fell 8% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.35 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anexas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Anexas Pharmaceuticals Private Limited
Anexas Pharmaceuticals has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monika Saxena | Director | 29 May 2020 | 6 Years 5 Months | Current |
| Ajeet Kumar Saxena | Director | 26 Nov 2019 | 6 Years 11 Months | Current |
| Sujeet Kumar Saxena | Director | 26 Nov 2019 | 6 Years 11 Months | Current |
| Anupama Saxena | Director | 26 Nov 2019 | 6 Years 11 Months | Current |
| Devansh Saxena | Director | 28 Apr 2022 | 4 Years 6 Months | Current |
| Divya Saxena | Director | 28 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
Anexas Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kansas Drugs & Pharmaceuticals Pvt.Ltd. | ₹4.43 Cr (FY 2023) | 11.0% | Kolkata, West Bengal, India | |||
| Lifegrace Pharmaceuticals Private Limited | ₹4.43 Cr (FY 2025) | 25.0% | Delhi, India | |||
| Oxinium Pharmaceuticals Private Limited | ₹4.36 Cr (FY 2024) | 35.0% | Jaysingpur, Maharashtra, India | |||
| Anexas Pharmaceuticals Private Limitedthis company | ₹4.34 Cr (FY 2025) | ₹1.91 Lakh | 0.4% | -8.0% | Agra, Uttar Pradesh, India |
To see the full peer comparison of Anexas Pharmaceuticals Private Limited, buy the company report.
Auditor
Anexas Pharmaceuticals Private Limited is audited by P G M A & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P G M A & ASSOCIATES | FY 2022 | 007865C |
Shareholding
The shareholding of Anexas Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Anexas Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Sep 2020 | 100371671 | Others | ₹1 Cr | Open |
To see the full charge records of Anexas Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Anexas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anexas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anexas Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AASCA9864D1Z2 | Uttar Pradesh | Active | 25 Mar 2020 |
To see the full GST registrations and return filing status of Anexas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Anexas Pharmaceuticals Private Limited has 13 board changes on record since 2019: 8 appointments and 5 cessations. The latest: Devansh Saxena ceased to be Additional Director on 29 Sep 2022.
AGM
Anexas Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Anexas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Devansh Saxena ceased to be Additional Director.
Ceased
Divya Saxena ceased to be Additional Director.
Ceased
Muskan Saxena ceased to be Additional Director.
Ceased
Pankhuri Saxena ceased to be Additional Director.
Charges
A charge with Others of Rs. 100.00 Lakh registered on 08 Sep 2020 with Charge ID 100371671 was modified on 21 Sep 2022.
Appointed
Devansh Saxena was appointed as Director.
Appointed
Divya Saxena was appointed as Director.
Appointed
Muskan Saxena was appointed as Director.
Appointed
Pankhuri Saxena was appointed as Director.
Ceased
Monika Saxena ceased to be Additional Director.
6 earlier events are in the company report.
Frequently asked questions
Anexas Pharmaceuticals is an active private limited company based in Agra, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 November 2019 (7+ years old) and is registered under CIN U74999UP2019PTC123830.
Anexas Pharmaceuticals has 6 current directors:
- Monika Saxena - Director
- Ajeet Kumar Saxena - Director
- Sujeet Kumar Saxena - Director
- Anupama Saxena - Director
- Devansh Saxena - Director
- Divya Saxena - Director
The latest financial statements of Anexas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Anexas Pharmaceuticals is 09AASCA9864D1Z2, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Anexas Pharmaceuticals is U74999UP2019PTC123830. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anexas Pharmaceuticals was incorporated on 26 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Anexas Pharmaceuticals by revenue are Kansas Drugs & Pharmaceuticals Pvt.Ltd, Lifegrace Pharmaceuticals Private Limited, Oxinium Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Devansh Saxena ceased to be Additional Director on 29 Sep 2022. Divya Saxena ceased to be Additional Director on 29 Sep 2022. Muskan Saxena ceased to be Additional Director on 29 Sep 2022. Anexas Pharmaceuticals has 13 board changes on record in total.
Yes, Anexas Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-01-0042790).
Anexas Pharmaceuticals can be reached through the website anexaspharma.com. Its registered office is in Agra, Uttar Pradesh, India.
The registered office of Anexas Pharmaceuticals is at D – 9 Jai Ram Bagh Nagla Baghel Dayal Bagh, Agra, Uttar Pradesh, India – 282005.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages